Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Albanell, J
661  Ergebnisse:
Personensuche X
?
1

Randomized phase II study of fulvestrant plus palbociclib o..:

Albanell, J. ; Martínez, M.T. ; Ramos, M....
European Journal of Cancer.  161 (2022)  - p. 26-37 , 2022
Link: https://doi.org/10.1016/..
 
?
2

PCN78 Costs of Recurrence in Patients with HER2+ Breast Can..:

Albanell, J. ; Colomer, R. ; Martín, M....
Value in Health.  23 (2020)  - p. S435 , 2020
Link: https://doi.org/10.1016/..
 
?
3

PCN79 IMPACT of Adjuvant Trastuzumab Emtansine (T-DM1) on t..:

Martín, M. ; Albanell, J. ; Moreno, E....
Value in Health.  23 (2020)  - p. S435-S436 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Correction to: Biomarkers in breast cancer: A consensus sta..:

Colomer, R. ; Aranda-López, I. ; Albanell, J....
Clinical and Translational Oncology.  20 (2018)  8 - p. 1093-1095 , 2018
Link: https://doi.org/10.1007/..
 
?
5

PCN20 - CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPRO..:

Ciruelos, E. ; Alba, E. ; Lopez, R....
Value in Health.  21 (2018)  - p. S18 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Assessment of neuronal autoantibodies in patients with smal..:

Hardy-Werbin, M. ; Arpí, O. ; Taus, A....
OncoImmunology.  7 (2017)  2 - p. , 2017
Link: https://doi.org/10.1080/..
 
?
7

Plasma ctDNA RAS mutation analysis for the diagnosis and tr..:

Vidal, J. ; Muinelo, L. ; Dalmases, A....
Annals of Oncology.  28 (2017)  6 - p. 1325-1332 , 2017
Link: https://doi.org/10.1093/..
 
?
8

Biomarkers in breast cancer: A consensus statement by the S..:

Colomer, R. ; Aranda-López, I. ; Albanell, J....
Clinical and Translational Oncology.  20 (2017)  7 - p. 815-826 , 2017
Link: https://doi.org/10.1007/..
 
?
9

CIP2A confirms its prognostic value in triple-negative brea..:

Cristóbal, I ; Zazo, S ; Torrejón, B...
Oncogene.  36 (2017)  23 - p. 3357-3358 , 2017
Link: https://doi.org/10.1038/..
 
?
10

Real World Evidence In Europe - The Results Of An Expert Su..:

Gill, JL ; Albanell, J ; Avouac, B...
Value in Health.  20 (2017)  9 - p. A655 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Identification of molecular mechanisms of acquired resistan..:

Sampera, A. ; Gelabert-Baldrich, M. ; Sánchez-Martín, F.J....
European Journal of Cancer.  61 (2016)  - p. S124-S125 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Targeting the PI3K/AKT/mTOR pathway with a dual mTORC1/2 in..:

Hernández-Prat, A. ; Martinez, A. ; Arpí, O....
European Journal of Cancer.  61 (2016)  - p. S141 , 2016
Link: https://doi.org/10.1016/..
 
?
13

A definition for aggressive disease in patients with HER-2 ..:

González, A. ; Lluch, A. ; Aba, E....
Clinical and Translational Oncology.  19 (2016)  5 - p. 616-624 , 2016
Link: https://doi.org/10.1007/..
 
?
14

Cost-Utility Analysis of Neoadjuvant Chemotherapy with Pert..:

Colomer, R ; Ciruelos, E ; De la Haba, J...
Value in Health.  19 (2016)  7 - p. A740 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Estimated Costs of Locoregional and Metastatic Recurrences ..:

Albanell, J ; Ciruelos, E ; De la Haba, J...
Value in Health.  19 (2016)  7 - p. A729 , 2016
Link: https://doi.org/10.1016/..
 
1-15